Patent Assignment
Reel/Frame 018925/0677
Assignment of Assignor's Interest
Recorded: 2007-02-23
Pages: 2
Assignor
VALEANT RESEARCH & DEVELOPMENT
Executed: 2006-12-21
Assignee
INTRABIOTICS PHARMACEUTICALS, INC.
1009 OAK HILL ROAD, SUITE 201, LAFAYETTE, CALIFORNIA, 94549
Covered Property
(1)
Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
Application:
60/833,886 →
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 8, 2006
From: MADERNA, ANDREAS; HONG, ZHI; VERNIER, JEAN-MICHEL
To: VALEANT RESEARCH & DEVELOPMENT
Reel/Frame 018495/0782 →
Change of Name
Mar 1, 2007
From: INTRABIOTICS PHARMACEUTICALS, INC.
To: ARDEA BIOSCIENCES, INC.
Reel/Frame 018946/0357 →
Security Agreement
Oct 4, 2010
From: ATON PHARMA, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA; VALEANT PHARMACEUTICALS INTERNATIONAL; CORIA LABORATORIES, LTD.
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 025084/0169 →
Patent Security Release Agreement
Mar 14, 2011
From: GOLDMAN SACHS LENDING PARTNERS LLC
To: VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS NORTH AMERICA; CORIA LABORATORIES, LTD.; DOW PHARMACEUTICAL SCIENCES, INC.
Reel/Frame 025950/0048 →